Show simple item record

dc.contributor.authorNyandwaro, Kevin
dc.contributor.authorOyweri, Job
dc.contributor.authorKimani, Francis
dc.contributor.authorMbugua, Amos
dc.date.accessioned2024-03-25T14:03:58Z
dc.date.available2024-03-25T14:03:58Z
dc.date.issued2020-02-17
dc.identifier.urihttps://repository.maseno.ac.ke/handle/123456789/6063
dc.descriptionArticle ID 7605730 | https://doi.org/10.1155/2020/7605730en_US
dc.description.abstractPlasmodium parasite resistance to artemisinin-based combination therapies (ACTs) calls for development of new, affordable, safe, and effective antimalarial drugs. Studies conducted previously on soybean extracts have established that they possess antimicrobial, anti-inflammatory, anticancerous, and antioxidant properties. The activity of such extracts on Plasmodium parasites has not been potentially exploited. Objectives. The aim of this study was to determine the antiplasmodial activity of soybean extracts using Plasmodium falciparum cultures, followed by an in vivo evaluation of safety and antimalarial activity of the extracts in Plasmodium berghei ANKA strain-infected mice.en_US
dc.publisherHindawien_US
dc.titleEvaluating Antiplasmodial and Antimalarial Activities of Soybean (Glycine max) Seed Extracts on P. falciparum Parasite Cultures and P. berghei-Infected Miceen_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record